BDBM50023325 2-Isopropyl-11-oxo-11H-pyrido[2,1-b]quinazoline-8-carboxylic acid (6-pyrimidin-5-yl-hexyl)-amide::CHEMBL141825
SMILES: CC(C)c1ccc2nc3ccc(cn3c(=O)c2c1)C(=O)NCCCCCCc1cncnc1
InChI Key: InChIKey=XMGWUMLCQPDZIO-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Platelet activating factor receptor (Homo sapiens (Human)) | BDBM50023325 (2-Isopropyl-11-oxo-11H-pyrido[2,1-b]quinazoline-8-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 200 | n/a | n/a | n/a | n/a | n/a | n/a |
Hoffmann-La Roche Inc. Curated by ChEMBL | Assay Description Ability to inhibit platelet activating factor (PAF) binding to platelets by 50% was determined by using [3H]-PAF as radioligand | J Med Chem 31: 466-72 (1988) BindingDB Entry DOI: 10.7270/Q2KK99S6 | |||||||||||
More data for this Ligand-Target Pair |